The voice of medical imaging and clinical oncology

PETMR

Is PETMR more accurate than PETCT imaging in the staging and management of gynaecological cancers?

Gynaecological cancers, those originating in the cervix, uterus, ovary, vulva and vagina, account for approximately one-quarter of all malignant disease in women. According to Cancer Research UK, approximately 21,760 new gynaecological cancers were diagnosed in 2016. Effective treatment planning is reliant upon precise and accurate staging. PETCT is used in the staging and management of […]

Erin Whiffing, Hollie Hadwen

Alliance Medical, University of Suffolk

Read Article

Imaging of infection in nuclear medicine

Knowledge of the pathophysiology of infection and inflammation has developed greatly since the introduction of infection imaging techniques in nuclear medicine in the second half of the 20th century. Radionuclide imaging of infection is no longer singularly the visualisation of a generalised process but the molecular depiction of different pathways in infectious and inflammatory processes. […]

André Nunes

Guy’s and St Thomas' NHS Foundation Trust

Read Article

Artefacts and diagnostic pitfalls in PETMRI

PETMRI has recently been introduced into clinical practice. It maximises diagnostic information by unifying the excellent anatomical morphological and functional information available from MRI and the molecular and metabolic information from PET. PETMRI is currently one of the most active areas of research in diagnostic imaging, and areas where this modality can bring potential benefits […]

Andrew Mallia, Gary Cook, Vicky Goh, Radhouene Neji, Jane Mackewn, James Stirling, Sami Jeljeli

King's College London, Guy's and St Thomas' NHS Foundation Trust

Read Article

PETMRI in oncology

Combined positron emission tomography/ magnetic resonance imaging (PETMRI) has received heightened interest recently with the introduction of commercially available systems having full body imaging capability. PET imaging with radiolabelled tracers, the most widely used being F18-deoxyglucose (FDG), allows direct probing of metabolism with exquisite sensitivity, demonstrating pathophysiological change before any structural change becomes apparent. With […]

Sofia Michopouolou, David Brown, Simon Wan

University College London Hospitals NHS Foundation Trust

Read Article

Advertise: mechel@radmagazine.com

Subscribe: katherine@radmagazine.com

Call: (01371) 812960

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.